Regional Anesthesia for Cardiothoracic Enhanced Recovery
| Status: | Not yet recruiting |
|---|---|
| Conditions: | Peripheral Vascular Disease, Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 18 - 100 |
| Updated: | 12/21/2018 |
| Start Date: | January 30, 2019 |
| End Date: | October 30, 2022 |
| Contact: | Jessica Brodt, MD |
| Email: | jbrodt@stanford.edu |
| Phone: | 350-331-1075 |
Regional Anesthesia for Cardiothoracic Enhanced Recovery for Patients Undergoing Cardiac Surgery Via Sternotomy
The erector spinae plane block (ESPB) is a novel regional analgesic technique that provides
pain relief with a peripheral nerve block catheter. The goal of this study is to see if
bilateral ESPB catheters can improve clinical outcomes in patients undergoing cardiac surgery
via sternotomy, such as decreasing the duration of postoperative mechanical ventilation, need
for intravenous opioid medications, length of stay in the intensive care unit (ICU), and
improving pain scores.
pain relief with a peripheral nerve block catheter. The goal of this study is to see if
bilateral ESPB catheters can improve clinical outcomes in patients undergoing cardiac surgery
via sternotomy, such as decreasing the duration of postoperative mechanical ventilation, need
for intravenous opioid medications, length of stay in the intensive care unit (ICU), and
improving pain scores.
Inclusion Criteria:
- Give consent to participate in study
- planned sternotomy
- specific procedures: CABG (coronary artery bypass grafting) or AVR (aortic valve
repair or replacement) or MVR (mitral valve repair or replacement) or combination of
any of 2 of these
- Primary or first redo sternotomy
Exclusion Criteria:
- Participants who cannot give consent
- Patients who are clinically unstable or require urgent/emergent intervention
- more than1 prior sternotomy
- planned aortic arch procedures
- preoperative coagulopathy (INR >1.5, PTT >35) or ongoing anticoagulation (heparin
infusion, therapeutic low molecular weight heparin, warfarin, dual antiplatelet
therapy)
- Severe ventricular dysfunction (left or right ventricle)
- Known heart failure (systolic or diastolic)
We found this trial at
1
site
Stanford University Stanford University, located between San Francisco and San Jose in the heart of...
Click here to add this to my saved trials
